education
Download App
Indonesia
search
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Download App
Country
Indonesia
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Iklan
Iklan
MIMS home
Drugs
Info
Analsik
Analsik
Manufacturer:
Sanbe
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Contents
Methampyrone 500 mg, diazepam 2 mg
Indications/Uses
Relief of moderate to severe pain, especially colic & post-op when the combination w/ tranquilizer is needed.
Dosage/Direction for Use
Adult
1 caplet, if pain persist, followed by 1 cap 6-8 hrly. Max: 4 caplet daily.
Administration
Should be taken with food.
Contraindications
BP <100 mmHg, acute psychosis. Pregnancy & lactation. Infant 1st mth birth.
Special Precautions
Hepatic & renal dysfunction, severely depressed patients, blood disorders.
Adverse Reactions
Agranulocytosis, hypersensitivity reactions, skin reactions, drowsiness, dizziness, constipation, depression, hypotension, nausea, tremor, urinary retention, vertigo.
View
ADR Reporting Link
Drug Interactions
Chlorpromazine, cimetidine, alcohol, other CNS depressants.
MIMS Class
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
ATC Classification
N02BB72 - metamizole sodium, combinations with psycholeptics ; Belongs to the class of pyrazolone preparations. Used to relieve pain and fever.
Regulatory Classification
K
Presentation/Packing
Form
Analsik FC caplet
Packing/Price
10 × 10's (Rp175,000/boks, Rp1,750/FC caplet)
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk